Rapid Mycobacterium abscessus antimicrobial susceptibility testing based on antibiotic treatment response mapping via Raman Microspectroscopy.
Antimicrobial susceptibility test
Clarithromycin
D2O-probed Raman microspectroscopy
Linezolid
Mycobacterium abscessus
Journal
Annals of clinical microbiology and antimicrobials
ISSN: 1476-0711
Titre abrégé: Ann Clin Microbiol Antimicrob
Pays: England
ID NLM: 101152152
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
16
07
2023
accepted:
17
10
2023
medline:
2
11
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
Antimicrobial susceptibility tests (ASTs) are pivotal tools for detecting and combating infections caused by multidrug-resistant rapidly growing mycobacteria (RGM) but are time-consuming and labor-intensive. We used a Mycobacterium abscessus-based RGM model to develop a rapid (24-h) AST from the beginning of the strain culture, the Clinical Antimicrobials Susceptibility Test Ramanometry for RGM (CAST-R-RGM). The ASTs obtained for 21 clarithromycin (CLA)-treated and 18 linezolid (LZD)-treated RGM isolates. CAST-R-RGM employs D Ultimately, the rapid, accurate, and low-cost CAST-R-RGM assay offers advantages over conventional culture-based ASTs that warrant its use as a tool for improving patient treatment outcomes and revealing bacterial drug resistance mechanisms.
Identifiants
pubmed: 37904155
doi: 10.1186/s12941-023-00644-5
pii: 10.1186/s12941-023-00644-5
pmc: PMC10617219
doi:
Substances chimiques
Clarithromycin
H1250JIK0A
Linezolid
ISQ9I6J12J
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
94Subventions
Organisme : the Beijing Municipal Science & Technology Commission
ID : No. Z221100007422056
Organisme : National Natural Science Foundation of China
ID : 31827801
Organisme : the Beijing Hospitals Authority Ascent Plan
ID : DFL20191601
Informations de copyright
© 2023. The Author(s).
Références
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28893776
J Mol Diagn. 2021 Nov;23(11):1460-1467
pubmed: 34454109
Evol Appl. 2018 Jun 21;11(9):1498-1511
pubmed: 30344622
ACS Sens. 2022 May 27;7(5):1403-1418
pubmed: 35561012
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29436417
J Clin Microbiol. 2001 Feb;39(2):816-9
pubmed: 11158161
Clin Infect Dis. 2006 Jun 15;42(12):1756-63
pubmed: 16705584
J Clin Lab Anal. 2016 Sep;30(5):751-5
pubmed: 27169515
J Clin Microbiol. 2020 Sep 22;58(10):
pubmed: 32759357
Adv Sci (Weinh). 2023 Jun;10(16):e2207497
pubmed: 36871147
Anal Chem. 2021 Mar 30;93(12):5098-5106
pubmed: 33728890
J Antimicrob Chemother. 2012 Apr;67(4):810-8
pubmed: 22290346
Infect Drug Resist. 2020 Feb 12;13:447-454
pubmed: 32104016
Infect Genet Evol. 2019 Aug;72:169-182
pubmed: 30315892
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0072021
pubmed: 34181476
Semin Respir Crit Care Med. 2008 Oct;29(5):577-88
pubmed: 18810691
Microorganisms. 2020 May 09;8(5):
pubmed: 32397563
Antibiotics (Basel). 2020 Oct 17;9(10):
pubmed: 33080864
Appl Microbiol Biotechnol. 2016 Mar;100(5):2355-65
pubmed: 26754815
Microbiol Spectr. 2022 Jun 29;10(3):e0057422
pubmed: 35638787
Adv Sci (Weinh). 2020 Aug 16;7(19):2001452
pubmed: 33042757
Anal Chem. 2017 Apr 4;89(7):4108-4115
pubmed: 28282113
Nat Microbiol. 2019 Dec;4(12):2109-2117
pubmed: 31451773
Bioinformatics. 2012 Sep 1;28(17):2270-1
pubmed: 22796955
Front Microbiol. 2022 Aug 04;13:936726
pubmed: 35992656
Sci Rep. 2016 Oct 19;6:34359
pubmed: 27756907
Anal Chem. 2019 May 7;91(9):6296-6303
pubmed: 30942570
Anal Chem. 2018 Mar 20;90(6):3737-3743
pubmed: 29461044
Anal Chem. 2020 Jul 7;92(13):8722-8731
pubmed: 32285664
Nat Rev Microbiol. 2020 Jul;18(7):392-407
pubmed: 32086501
Anal Chem. 2021 Feb 2;93(4):2125-2134
pubmed: 33435684
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30397069
Biotechnol Adv. 2019 Nov 1;37(6):107388
pubmed: 31152870
Clin Chem. 2022 Jul 27;68(8):1064-1074
pubmed: 35714147